Skip to content

The Actual News

Stay informed without the news wearing you out.

Researchers Studied Two Alzheimer’s Groups. One Brain Difference Stood Out

Researchers Studied Two Alzheimer’s Groups. One Brain Difference Stood Out

Summary

A study of 66 people along the Alzheimer’s disease continuum found reduced glucose metabolism in similar brain regions across two patient groups. The biological factors linked to that reduction differed: tau-related measures in one group, and blood-brain barrier dysfunction and amyloid-related changes in the other.

Key Facts

  • The study included 66 people along the Alzheimer’s disease continuum and 41 cognitively healthy participants.
  • Researchers divided patients into groups based on biomarkers for amyloid, tau and neurodegeneration.
  • Both Alzheimer’s groups showed reduced glucose metabolism in temporoparietal brain areas involved in memory and cognitive processing.
  • In the group with elevated tau biomarkers, glucose metabolism was associated with tau-related measures.
  • In the group without elevated phosphorylated tau, poorer metabolism in posterior brain regions was associated with greater blood-brain barrier dysfunction and amyloid-related changes.
  • The group without elevated phosphorylated tau had higher average cerebrospinal-fluid-to-serum albumin ratios, an indicator of blood-brain barrier impairment.
  • The study’s findings were published in the journal Aging.
Read the Full Article

This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.

The week's biggest stories, one calm email every Monday.